Gujarat Kidney And Super Speciality Limited has shared Monitoring Agency Report for Quarter ended on 31.03.2026
GKSL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gujarat Kidney and Super Speciality Limited submitted its second Monitoring Agency Report by Brickwork Ratings for the quarter ended March 31, 2026. The company raised ₹250.80 crore through an IPO in December 2025. As of March 31, 2026, ₹100.15 crore (40%) has been utilized, leaving ₹150.65 crore unutilized. Three acquisitions have been completed: Parekhs Hospital (₹77 crore), Ashwini Medical Centre (₹12.40 crore), and additional stake in subsidiary Harmony Medicare (₹10.78 crore). ₹50.04 crore was deployed during the quarter, primarily for general corporate purposes (₹24.78 crore) and issue expenses (₹5.25 crore). Setting up of new Vadodara hospital is ongoing with ₹4.95 crore utilized out of ₹30.09 crore planned. Robotics equipment purchase remains completely unutilized at ₹6.83 crore.
The report shows moderate utilization of IPO proceeds with no deviations from stated objects. Unutilized funds of ₹150.65 crore are largely parked in fixed deposits earning 5.75% returns, suggesting the company is proceeding cautiously with acquisitions and capital expenditure. Three hospital acquisitions completed should provide near-term revenue support.